These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6488445)

  • 1. Bronchopulmonary effects of elliptinium in anesthetized dogs.
    Eschalier A; Lavarenne J; Renoux M
    Cancer Chemother Pharmacol; 1984; 13(3):240-1. PubMed ID: 6488445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular effects of elliptinium. The mechanism of action].
    Eschalier A; Lavarenne J; Dureng G; Rodriguez M; Tounissou P
    J Pharmacol; 1984; 15(3):301-8. PubMed ID: 6492819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and vascular effects of elliptinium in guinea pigs. Involvement of a histaminergic mechanism.
    Eschalier A; Lavarenne J; Renoux M; Tounissou P
    Agents Actions; 1985 Jul; 16(5):302-5. PubMed ID: 4050612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of an antitumoral agent: elliptinium. Involvement of histamine release.
    Eschalier A; Lavarenne J; Burtin C; Tounissou P
    Agents Actions; 1986 Mar; 17(5-6):441-8. PubMed ID: 2422901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium.
    Umbach GE; Hug V; Spitzer G; Thames H; Drewinko B
    Invest New Drugs; 1984; 2(3):263-5. PubMed ID: 6210262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary analysis of the effects of elliptinium on immune reactivities in mice.
    Gallotta ES; Sironi M; Spreafico F; Vecchi A
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):637-45. PubMed ID: 3527714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can iron salts mediate the degradation of nucleos(t)ides by elliptinium acetate via free-radicals?
    Dugue B; Meunier B
    Biochem Biophys Res Commun; 1985 Nov; 133(1):15-22. PubMed ID: 3000372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent bronchoconstrictor effects of aerosolized prostaglandin D2 in dogs.
    Wasserman MA; Griffin RL; Marsalisi FB
    Prostaglandins; 1980 Oct; 20(4):703-15. PubMed ID: 7465863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virostatic in vivo effect of elliptinium on Friend's retrovirus (a model for HIV infection).
    Mathé G; Chenu E; Bourut C
    Biomed Pharmacother; 1990; 44(1):1-3. PubMed ID: 1369686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugates of elliptinium acetate with mouse monoclonal anti-alpha-fetoprotein antibodies or Fab fragments: in vitro cytotoxic effects upon human hepatoma cell lines.
    Alberici GF; Pallardy M; Manil L; Dessaux JJ; Fournier J; Mondesir JM; Bohuon C; Gros P
    Int J Cancer; 1988 Feb; 41(2):309-14. PubMed ID: 2448254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of the histaminic component of the bronchoconstrictor and cardiovascular effects of anaphylatoxin in the guinea-pig.
    Sackeyfio AC
    Br J Pharmacol; 1971 Oct; 43(2):424P-425P. PubMed ID: 4110353
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal antibodies to elliptinium acetate: structure-activity relationships and comparison with human anti-elliptinium IgM.
    Pallardy M; Alberici GF; Dessaux JJ; Bohuon C
    Int J Immunopharmacol; 1987; 9(2):151-6. PubMed ID: 3583508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine-releasing properties of hydroxy-9-methyl-2-ellipticinium acetate.
    Eschalier A; Advenier C; Lebel B; Burtin C; Lavarenne J
    Cancer Chemother Pharmacol; 1981; 5(4):233-6. PubMed ID: 6167376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human antibodies to the antineoplastic drug elliptinium: characterization and structure-activity relationships.
    Alberici GF; Fellous R; Bidart JM; Troalen F; Mondesir JM; Goodman A; Ho DH; Bohuon C
    J Allergy Clin Immunol; 1986 Apr; 77(4):624-30. PubMed ID: 2420854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elliptinium acetate in metastatic breast cancer--a phase II study.
    Buzdar AU; Hortobagyi GN; Esparza LT; Holmes FA; Ro JS; Fraschini G; Lichtiger B
    Oncology; 1990; 47(2):101-4. PubMed ID: 2314820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachyphylaxis to inhaled aerosolized histamine in anesthetized dogs.
    Shore S; Martin JG
    J Appl Physiol (1985); 1985 Nov; 59(5):1355-63. PubMed ID: 4066565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies of lycorenine, an alkaloid of Lycoris radiata Herb.: II. Effects of blood pressure in rats and dogs and the mechanism of tachyphylaxis to the vasodepressor action of lycorenine in rats.
    Miyasaka K; Hiramatsu Y
    Jpn J Pharmacol; 1980 Oct; 30(5):655-64. PubMed ID: 6110797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and pulmonary effects of thromboxane B2 in the dog.
    Friedman LS; Fitzpatrick TM; Bloom MF; Ramwell PW; Rose JC; Kot PA
    Circ Res; 1979 Jun; 44(6):748-51. PubMed ID: 428069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoconstrictor effects of leukotriene B4 in the guinea pig in vivo.
    Hamel R; Ford-Hutchinson AW
    Prostaglandins; 1983 Mar; 25(3):405-12. PubMed ID: 6306730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.